Last quarter (Q ), Epizyme's total revenue was $27.53M, an increase of 111.59% from the same quarter last year. In Q, Epizyme's net income was $-35.74M. See Epizyme’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 53.01M	$ 37.43M	$ 15.76M	$ 23.80M	$ 21.70M	$ 10.00M
Cost of Revenue	$ 12.95M	$ 10.50M	$ 5.07M	$ 0.00	$ 0.00	-
Gross Profit	$ 40.06M	$ 26.93M	$ 10.70M	$ 23.80M	$ 21.70M	-
Operating Expense	$ 236.21M	$ 264.92M	$ 236.11M	$ 200.94M	$ 149.81M	$ 146.84M
Operating Income	$ -196.15M	$ -237.99M	$ -225.42M	$ -177.14M	$ -128.10M	$ -136.84M
Net Non Operating Interest Income Expense	$ -23.79M	$ -24.16M	$ -6.07M	$ 6.92M	$ 4.56M	$ 2.17M
Other Income Expense	$ 12.24M	$ 11.05M	$ -99.00K	$ -13.00K	$ -25.00K	$ 32.00K
Pretax Income	$ -207.68M	$ -251.10M	$ -231.58M	$ -170.24M	$ -123.57M	$ -134.65M
Tax Provision	$ 53.00K	$ 22.00K	$ 114.00K	$ 58.00K	$ 57.00K	$ -336.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -207.73M	$ -251.12M	$ -231.69M	$ -173.24M	$ -123.63M	$ -134.31M
Basic EPS	$ -1.72	$ -2.45	$ -2.29	$ -1.93	$ -1.72	$ -2.18
Diluted EPS	$ -1.72	$ -2.45	$ -2.29	$ -1.93	$ -1.72	$ -2.18
Basic Average Shares	$ 517.92M	$ 102.65M	$ 100.96M	$ 89.89M	$ 71.86M	$ 61.47M
Diluted Average Shares	$ 517.92M	$ 102.65M	$ 100.96M	$ 89.89M	$ 71.86M	$ 61.47M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 249.16M	$ 275.42M	$ 241.18M	$ 200.94M	$ 149.81M	$ 146.84M
Net Income From Continuing And Discontinued Operation	$ -207.73M	$ -251.12M	$ -231.69M	$ -170.29M	$ -123.63M	$ -134.31M
Normalized Income	$ -219.66M	$ -262.24M	$ -231.69M	$ -170.29M	$ -123.63M	$ -134.31M
Interest Expense	$ 24.09M	$ 24.16M	$ 6.07M	$ 192.00K	$ 0.00	$ 0.00
EBIT	$ -183.59M	$ -226.94M	$ -225.51M	$ -170.04M	$ -123.57M	$ -134.65M
EBITDA	$ -178.36M	$ -221.69M	$ -221.53M	$ -169.21M	$ -122.52M	$ -133.01M

Currency in USD

Epizyme Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing